课题基金 / 基金详情

NEUROLOGICAL PREDICTORS OF HUNTINGTON DISEASE (PREDICT-HD)

NEUROLOGICAL PREDICTORS OF HUNTINGTON DISEASE (PREDICT-HD)
亨廷顿病的神经学预测因素 (PREDICT-HD)
批准号:
7606386
负责人:
Kimberly Andrea Quaid
金额:
$0.33万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

Kimberly Andrea Quaid的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Onset of disease is a vital outcome measure for therapeutic trials involving healthy persons who are at known risk for manifesting disease. The primary aim of this project is to characterize neurobiological and neurobehavioral markers of Huntington Disease (HD) prior to the development of clinically manifest motor symptoms. Subjects will be men and women ages 30-55 who are at risk for HD by virtue of having an affected parent and who have undergone genetic testing for HD (425 with CAG repeat > 39 and 75 with a CAG repeat < 30). Subjects will be examined once a year for 4 years. Assessment will include a neurological examination, extensive neurophyschological testing, psychological assessment, and magnetic resonance imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Testing for Huntington Disease in At Risk Adolescents and Young Adults
Genetic Testing for Huntington Disease in At Risk Adolescents and Young Adults
COOPERATIVE HUNTINGTON'S OBSERVATIONAL RESEARCH TRIAL (COHORT)
COOPERATIVE HUNTINGTON'S OBSERVATIONAL RESEARCH TRIAL (COHORT)
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: